• Dr. Padda with a patient

    Aiming to Refine NSCLC Targeted Therapy

    Dr. Padda has a national reputation in lung cancer precision oncology, and was the principal investigator on the first study on Sotorasib, a novel targeted therapy, for advanced KRAS G12C mutated non-small cell lung cancer.

  • Physician Reviewing imaging with a Patient

    WE NEVER STOP

    Discovering New Treatments. Delivering Better Outcomes. Providing Personalized Care. Focusing on You.

  • 50years

    Check Out Fox Chase’s New Annual Report

    Quick Links

    Find a Doctor

    Search for a specialist that is right for you

    Cancer Types & Conditions

    Learn about symptoms, risk factors, and our personalized treatments

    Clinical Trials

    Search our active clinical trials enrolling new patients

    News

    Events

    Publications

    Link to /sites/default/files/styles/max_width/public/images/blocks/promoted/21FC063-Website-Campus-Image-360x240-1.png?itok=xO1rz-EI

    Temple Health Strong

    Fox Chase Cancer Center is proud to be an integral part of Temple Health.  Along with offering our patients the best in cancer care, we also provide unparalleled access to a vast network of physicians, specialty clinical care for a variety of other healthcare needs, and groundbreaking clinical trials and treatments.